How Embedding SBD in SKYWAVE’s IoT Platform At Iridium Communications (IRDM) Has Changed Its Investment Story

Iridium Communications Inc.

Iridium Communications Inc.

IRDM

0.00

  • In July 2026, Iridium Communications Inc. announced a partnership with SKYWAVE to embed its global low Earth orbit satellite Short Burst Data services into SKYWAVE’s OGx IoT platform and satellite IoT terminals, giving heavy equipment manufacturers a way to maintain connected services across satellite, cellular, and Wi‑Fi networks in remote and harsh environments.
  • This integration could make Iridium’s network more deeply embedded in industrial IoT workflows, potentially broadening its role in remote monitoring, diagnostics, and predictive maintenance for global heavy equipment fleets.
  • Next, we’ll examine how embedding Iridium’s SBD into SKYWAVE’s multi-network IoT platform could influence the company’s long-term investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Iridium Communications Investment Narrative Recap

To own Iridium, you need to believe in its role as a critical connectivity backbone for hard to reach assets, especially in industrial IoT and resilient communications. The SKYWAVE partnership fits this thesis by embedding Iridium deeper into multi network equipment workflows, but it does not directly address near term pressure around slowing IoT service growth or competitive threats from emerging satellite and terrestrial direct to device offerings, which still look like the key swing factors.

Among recent announcements, the Q2 2026 earnings release stands out alongside this SKYWAVE news. Revenue grew to US$225.24 million from US$216.91 million a year earlier, while net income declined to US$9.68 million from US$21.97 million, highlighting margin pressure even as top line trends remained positive. For investors, that mix of modest growth and weaker profitability frames how much impact new IoT partnerships may need to have to influence the story.

Yet before leaning too hard on the upside from new IoT deals, investors should be aware that intensifying competition and Iridium’s concentrated narrowband focus could...

Iridium Communications' narrative projects $1.0 billion revenue and $170.7 million earnings by 2029.

Uncover how Iridium Communications' forecasts yield a $42.00 fair value, a 12% downside to its current price.

Exploring Other Perspectives

IRDM 1-Year Stock Price Chart
IRDM 1-Year Stock Price Chart

Some of the most optimistic analysts already expected Iridium to lift revenue to about US$951.0 million and earnings to roughly US$143.2 million by 2029, so if you worry about rivals like Starlink and Kuiper compressing margins, this SKYWAVE announcement could either support that bullish view or prompt a rethink, underscoring how differently you and other investors might see the same stock.

Explore 8 other fair value estimates on Iridium Communications - why the stock might be worth less than half the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Iridium Communications research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Iridium Communications research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Iridium Communications' overall financial health at a glance.

Looking For Alternative Opportunities?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

  • Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.
  • The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
  • AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.